N/A N=41 Randomized Double-blind Treatment

Enhancing Treatment of Hoarding Disorder With Personalized In-Home Sorting and Decluttering Practice

Hoarding Disorder · Hoarding · Clutter

Bottom Line

View on ClinicalTrials.gov: NCT02843308 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2025

Primary outcome: Primary: Number of Patients Who Met and Exceeded Response Criteria of the Saving Inventory-Revised (SI-R) — 9; 13 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Facilitated group therapy with behavioral practice; 18 weeks (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Stanford University
Primary completion: Jun 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Patients Who Met and Exceeded Response Criteria of the Saving Inventory-Revised (SI-R)	9; 13	—

Summary

The proposed study aims to investigate the efficacy of adding in-home decluttering practice to Buried in Treasures Workshop (BIT) facilitated group treatment for hoarding disorder.

Eligibility Criteria

Inclusion Criteria for Individuals with Hoarding Disorder:

Age 18 to 70 years
Either gender and all ethno-racial groups
Physically healthy male or non-pregnant female.
Hoarding Disorder primary condition
Willing and able to understand and complete consent and study procedures
English speaking

Exclusion Criteria for Individuals with Hoarding Disorder:

Current or past history of bipolar, psychotic or eating disorders, substance dependence, or substance abuse in the last year.
Clinically at risk of suicide with Columbia Suicide Severity Rating Scale (C-SSRS) Suicidal Ideation Subscale of 4 or higher (i.e. suicidal intent without specific plan)
Major medical or neurological conditions that increase the risk of participation or that would prevent completing assigned behavioral practice tasks.
Unable or unwilling to allow study staff into home for home assessment
Currently at high risk for eviction
Animal hoarding or squalor

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02843308). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.